|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0292 USD | -12.97% |
|
-26.08% | +12.31% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 18/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -12.97% | -26.08% | -18.89% | +192.00% | +12.31% | -91.21% | -96.88% | -99.19% | -99.61% | 7.74M | |
| +0.63% | -3.06% | +5.23% | -12.71% | -15.01% | +16.18% | -9.78% | +11.88% | +67.63% | 66.74B | |
| +1.23% | +2.80% | -3.53% | +2.93% | +3.10% | +37.51% | +202.14% | +172.67% | +249.23% | 53.32B | |
| +10.08% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | - | 48.12B | |
| -1.32% | -7.38% | -0.67% | -12.14% | -33.84% | -57.63% | -57.10% | -61.08% | -4.02% | 38.25B | |
| +0.78% | -1.84% | +1.30% | +9.66% | +14.89% | +52.49% | -27.01% | -37.86% | -29.74% | 29.85B | |
| +0.84% | +0.36% | +8.49% | +24.32% | +19.14% | +66.93% | +85.42% | +48.39% | +36.18% | 23.51B | |
| -5.17% | -12.54% | -10.51% | +6.58% | +83.35% | +58.98% | -56.04% | -84.50% | - | 21.45B | |
| -1.21% | +1.12% | +15.39% | +4.84% | +17.97% | +1.98% | +170.93% | +6.96% | - | 19.97B | |
| -0.22% | -0.95% | -2.93% | +14.29% | +37.44% | +61.97% | +123.78% | +166.71% | +329.89% | 16.38B | |
| +1.31% | +3.24% | +21.14% | +14.66% | +9.84% | +84.01% | +152.77% | +38.65% | - | 16.47B | |
| -0.22% | +4.78% | +1.29% | +29.60% | +31.95% | +129.59% | +227.89% | +348.96% | +3,005.67% | 12.4B | |
| +0.78% | -0.44% | +3.49% | +11.56% | -0.17% | -0.72% | -32.12% | -22.99% | -36.60% | 11.47B | |
| -1.96% | +8.68% | -19.11% | -18.56% | -33.15% | -37.00% | +612.09% | +318.33% | +4,513.22% | 11.02B | |
| +2.35% | -5.54% | -3.58% | +23.00% | +35.96% | +123.46% | +187.52% | +453.12% | - | 9.88B | |
| +2.70% | +6.37% | +7.41% | +7.89% | -9.76% | -20.85% | -27.32% | -53.58% | -52.33% | 6.62B | |
| -4.22% | -3.11% | -0.42% | -20.10% | +3.94% | +5.75% | +215.57% | +221.80% | - | 5.65B | |
| -5.03% | -1.51% | +11.15% | +4.78% | -7.01% | +6.14% | +45.28% | -21.86% | - | 5.56B | |
| -2.35% | -3.81% | -1.18% | +48.13% | +184.58% | +157.33% | +259.78% | -23.07% | - | 5.62B | |
| -1.65% | +7.00% | +5.24% | -24.08% | -28.54% | -43.16% | +132.88% | +120.41% | +117.09% | 5.49B | |
| Average | -0.48% | -0.92% | +3.56% | +17.92% | +18.94% | +30.18% | +108.08% | +77.78% | +674.72% | 20.39B | |
| Weighted average by Cap. | +1.34% | +0.41% | +7.82% | +8.67% | +13.15% | +32.37% | +80.74% | +61.83% | +399.59% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
